Stock 2160 GNI GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart GNI Group Ltd.

Equities

2160

JP3386370005

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-11 am EDT 		5-day change 1st Jan Change
2,441 JPY +0.66% Intraday chart for GNI Group Ltd. +2.61% -13.75%
Jul. 01 GNI Group Ltd. Announces GYRE Pharmaceuticals Receives Approval from the National Medical Products Administration for Avatrombopag Maleate Tablets CI
May. 31 Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GNI GROUP LTD. Stock GNI Group Ltd.
 750M - -
MODERNA, INC. Stock Moderna, Inc.
 45.01B -
LONZA GROUP AG Stock Lonza Group AG
 40.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.62B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 32.6B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.49B
  1. Stock Market
  2. Equities
  3. 2160 Stock
  4. Charts GNI Group Ltd.
  5. Sector Chart